SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001683168-20-004391
Filing Date
2020-12-21
Accepted
2020-12-21 08:38:40
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-1 cns_s1.htm S-1 305311
2 FORM OF UNDERWRITING AGREEMENT cns_ex0101.htm EX-1.1 267907
3 FORM OF PRE-FUNDED COMMON STOCK PURCHASE WARRANT cns_ex0404.htm EX-4.4 105236
4 LEGAL OPINION cns_ex0501.htm EX-5.1 11850
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM cns_ex2301.htm EX-23.1 2420
  Complete submission text file 0001683168-20-004391.txt   693714
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-251530 | Film No.: 201402507
SIC: 2834 Pharmaceutical Preparations